Literature DB >> 28357585

Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'.

Xian-Kun Tu1,2, Miki Fujimura3, Sherif Rashad1, Shunji Mugikura4, Hiroyuki Sakata1, Kuniyasu Niizuma1, Teiji Tominaga1.   

Abstract

Superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis is the standard surgical treatment for moyamoya disease (MMD). The main potential complications of this treatment are cerebral hyperperfusion (CHP) syndrome and ischemia, and their managements are contradictory to each other. We retrospectively investigated the incidence of the simultaneous manifestation of CHP and infarction after surgery for MMD. Of the 162 consecutive direct revascularization surgeries performed for MMD, we encountered two adult cases (1.2%) manifesting the simultaneous occurrence of symptomatic CHP and remote infarction in the acute stage. A 47-year-old man initially presenting with infarction developed CHP syndrome (aphasia) 2 days after left STA-MCA anastomosis, as assessed by quantitative single-photon emission computed tomography (SPECT). Although lowering blood pressure ameliorated his symptoms, he developed cerebral infarction at a remote area in the acute stage. Another 63-year-old man, who initially had progressing stroke, presented with aphasia due to focal CHP in the left temporal lobe associated with acute infarction at the tip of the left frontal lobe 1 day after left STA-MCA anastomosis, when SPECT showed a paradoxical decrease in cerebral blood flow (CBF) in the left frontal lobe despite a marked increase in CBF at the site of anastomosis. Symptoms were ameliorated in both patients with the normalization of CBF, and there were no further cerebrovascular events during the follow-up period. CHP and cerebral infarction may occur simultaneously not only due to blood pressure lowering against CHP, but also to the 'watershed shift' phenomenon, which needs to be elucidated in future studies.

Entities:  

Keywords:  Cerebral hyperperfusion; Cerebral infarction; Moyamoya disease; Surgical complication

Mesh:

Year:  2017        PMID: 28357585     DOI: 10.1007/s10143-017-0845-9

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  11 in total

1.  Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.

Authors:  Miki Fujimura; Takashi Inoue; Hiroaki Shimizu; Atsushi Saito; Shunji Mugikura; Teiji Tominaga
Journal:  Cerebrovasc Dis       Date:  2012-03-28       Impact factor: 2.762

2.  Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.

Authors:  Miki Fujimura; Kuniyasu Niizuma; Takashi Inoue; Kenichi Sato; Hidenori Endo; Hiroaki Shimizu; Teiji Tominaga
Journal:  Neurosurgery       Date:  2014-02       Impact factor: 4.654

Review 3.  Current status of revascularization surgery for Moyamoya disease: special consideration for its 'internal carotid-external carotid (IC-EC) conversion' as the physiological reorganization system.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Tohoku J Exp Med       Date:  2015-05       Impact factor: 1.848

4.  Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis).

Authors: 
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

5.  Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.

Authors:  Toshiaki Hayashi; Reizo Shirane; Miki Fujimura; Teiji Tominaga
Journal:  J Neurosurg Pediatr       Date:  2010-07       Impact factor: 2.375

6.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

7.  Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Shunji Mugikura; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2007-03

8.  Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.

Authors:  Miki Fujimura; Hiroaki Shimizu; Shunji Mugikura; Teiji Tominaga
Journal:  Surg Neurol       Date:  2008-03-04

9.  Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration.

Authors:  Jeong Eun Kim; Chang Wan Oh; O-Ki Kwon; Sukh Que Park; Sang Eun Kim; Yu Kyeong Kim
Journal:  Cerebrovasc Dis       Date:  2008-05-16       Impact factor: 2.762

10.  Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.

Authors:  Miki Fujimura; Shunji Mugikura; Tomohiro Kaneta; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2008-06-02
View more
  9 in total

1.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

2.  RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses.

Authors:  Liyin Zhang; Sherif Rashad; Yuan Zhou; Kuniyasu Niizuma; Teiji Tominaga
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-25       Impact factor: 6.960

3.  Limb-shaking syndrome derived from the contralateral hemisphere following unilateral revascularisation for moyamoya disease.

Authors:  Munehiro Demura; Masahiro Oishi; Naoyuki Uchiyama; Masanao Mohri; Katsuyoshi Miyashita; Mitsutoshi Nakada
Journal:  Surg Neurol Int       Date:  2021-11-23

4.  Paradoxical association of symptomatic cerebral edema with local hypoperfusion caused by the 'watershed shift' after revascularization surgery for adult moyamoya disease: a case report.

Authors:  Jin Yu; Miao Hu; Lei Yi; Keyao Zhou; Jianjian Zhang; Jincao Chen
Journal:  Ther Adv Neurol Disord       Date:  2019-09-25       Impact factor: 6.570

5.  The hemodynamic complexities underlying transient ischemic attacks in early-stage Moyamoya disease: an exploratory CFD study.

Authors:  Sherif Rashad; Khalid M Saqr; Miki Fujimura; Kuniyasu Niizuma; Teiji Tominaga
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

6.  Acute Thrombectomy for Contralateral Internal Carotid Artery Occlusion after Revascularization Surgery for Quasi-moyamoya Disease: A Case Report.

Authors:  Shotaro Ogawa; Daisuke Sato; Seiei Torazawa; Takahiro Ota
Journal:  NMC Case Rep J       Date:  2021-10-07

7.  Cerebral Hyperperfusion and Concomitant Reversible Lesion at the Splenium after Direct Revascularization Surgery for Adult Moyamoya Disease: Possible Involvement of MERS and Watershed Shift Phenomenon.

Authors:  Ryosuke Tashiro; Miki Fujimura; Taketo Nishizawa; Atsushi Saito; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-08-06

8.  Paradoxical symptomatic cerebral blood flow decreases after combined revascularization surgery for patients with pediatric moyamoya disease: illustrative case.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Kai Takayanagi; Kazuki Ishii; Masahiro Nishihori; Kazuhito Takeuchi; Kuniaki Tanahashi; Yuichi Nagata; Yusuke Nishimura; Sho Okamoto; Masaki Sumitomo; Takashi Izumi; Ryuta Saito
Journal:  J Neurosurg Case Lessons       Date:  2022-01-17

Review 9.  Severe cerebral edema induced by watershed shift after bypass in a patient with chronic steno-occlusive disease: a case report and short literature review.

Authors:  Yin Li; Yu-Yu Wei; Yang Cao; Xiao-Yang Lu; Yuan Yao; Lin Wang
Journal:  BMC Neurol       Date:  2020-09-05       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.